Shree Ganesh Remedies Limited , a prominent player in the pharmaceutical sector, has announced significant changes to its board composition and audit structure. The company's Board of Directors has made key decisions aimed at enhancing corporate governance and maintaining financial oversight.

New Independent Director Appointment

Ms. Shruti Sohane has been appointed as an Additional Director (Non-Executive, Independent) of Shree Ganesh Remedies Limited. The appointment, effective from August 08, 2025, is for a five-year term, subject to shareholder approval at the upcoming Annual General Meeting (AGM).

Ms. Sohane brings a wealth of experience to the board:

• Qualified Company Secretary with over a decade of experience in corporate governance and legal compliance
• Member of the Institute of Company Secretaries of India (ICSI) since 2014
• Commerce and law graduate from Nagpur University
• Known for her expertise in corporate laws, exceptional drafting skills, and solution-oriented approach to legal and regulatory matters

The company has confirmed that Ms. Sohane has not been debarred from holding the office of Director by any SEBI Order or other authority, ensuring compliance with regulatory requirements.

Cost Auditor Reappointment

In a move to maintain financial transparency and cost efficiency, Shree Ganesh Remedies has reappointed M/s. M. I. Prajapati & Associates as the Cost Auditor for the financial year 2025-2026. The reappointment comes with a remuneration of Rs. 55,000.00 plus applicable taxes, subject to shareholder approval at the upcoming AGM.

Key details of the Cost Auditor:

• CMA Mitesh Prajapati, proprietor of M. I. Prajapati & Associates, is a Fellow Member of ICMAI
• Completed CMA in 2011, ranking 71st All India in intermediate examinations
• Over 15 years of experience in preparing cost records and audit reports across various industries

Additional Board Decisions

The Board of Directors also made several other important decisions:

1. Appointed Mr. Vishal Thawani of M/s. Vishal Thawani & Associates, Practicing Company Secretaries, as the Scrutinizer for the e-voting process at the 30th AGM.
2. Approved the Notice for the 30th AGM along with the Directors' Report and its annexures for the year ended March 31, 2025.

These decisions reflect Shree Ganesh Remedies' commitment to maintaining high standards of corporate governance and ensuring transparent communication with its shareholders.

The board meeting, which took place on August 08, 2025, commenced at 12:30 p.m. and concluded at 01:15 p.m. These strategic moves are expected to strengthen the company's leadership and financial oversight in the pharmaceutical industry.

Shree Ganesh Remedies Limited , a pharmaceutical company, has been served with a GST summons from the Superintendent of Central GST and Central Excise Unit, Vadodara, alleging violations related to expired stock found at a company warehouse. The summons, which involves a potential GST liability of approximately Rs. 88.61 Lacs, has prompted the company to take immediate action.

Summons Details

The company received the summons on July 18, 2025, requiring them to appear before the authorities on July 21, 2025. The allegations center around expired stock discovered at a company warehouse that reportedly needs updates on re-testing dates.

Company's Response

Shree Ganesh Remedies, supported by legal and tax counsel, maintains that the claims are untenable under existing law and judicial precedents. The company has stated its intention to file an appeal before the appellate authority to contest the allegations.

Current Status

As of now, the investigation is at a preliminary stage. The company has emphasized that the summons have been issued, and they are actively addressing the situation.

Financial Implications

While the potential GST liability is estimated at Rs. 88.61 Lacs, Shree Ganesh Remedies believes that this will not result in any claims against the company. However, the exact financial impact remains to be seen as the case unfolds.

Regulatory Compliance

In compliance with SEBI regulations, Shree Ganesh Remedies has duly informed the BSE Limited about the summons under Regulation 30 of SEBI (LODR) Regulations, 2015. The company has committed to promptly update the Stock Exchanges regarding any material developments in this matter.

As the situation develops, stakeholders and investors will be closely watching how Shree Ganesh Remedies navigates this regulatory challenge and its potential impact on the company's operations and financial standing.